dibenzyl trisulfide has been researched along with Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clarke, N; Irvine, W | 1 |
| Bryant, JL; Facey, CO; Lowe, HI; Toyang, NJ | 1 |
2 other study(ies) available for dibenzyl trisulfide and Neoplasms
| Article | Year |
|---|---|
In Silico Design and SAR Study of Dibenzyl Trisulfide Analogues for Improved CYP1A1 Inhibition.
Topics: Benzyl Compounds; Cytochrome P-450 CYP1A1; Humans; Molecular Docking Simulation; Neoplasms; Sulfides | 2022 |
Specific RSK kinase inhibition by dibenzyl trisulfide and implication for therapeutic treatment of cancer.
Topics: Antineoplastic Agents; Benzyl Compounds; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Enzyme Activation; Humans; Neoplasms; Protein Kinase Inhibitors; Ribosomal Protein S6 Kinases; Sulfides | 2014 |